Results 201 to 210 of about 73,428 (238)

Multitargeted Aza-Arylcarboxamides for Neurodegenerative Diseases: Potent Histamine H₃ Receptor Ligands with Anticholinesterase and Metal-Chelating Activities. [PDF]

ACS Chem Neurosci
Lopes FB, Werner T, Bagatin IA, Stark H, Fernandes JPS.   +4 more
europepmc   +1 more source

Novel Dual 5-HT₇ Antagonists and Sodium Channel Inhibitors as Potential Therapeutic Agents with Antidepressant and Anxiolytic Activities. [PDF]

Pharmaceuticals (Basel)
Czopek A, Koczurkiewicz-Adamczyk P, Wójcik-Pszczoła K, Kornas D, Sitko W, Bucki A, Sapa M, Kamiński K, Satała G, Duszyńska B, Bojarski AJ, Latacz G, Czopek J, Szpor J, Dryja P, Sałat K.   +15 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Substituted Sulfonyl Piperazines

Journal of Pharmaceutical Sciences, 1962
Abstract In view of reports in the literature on the anticonvulsant action of various sulfonyl piperazines and of certain substituted 1-sulfonyl-4- β -aminoethylpiperazines as antishock agents, a series of mono- and disulfonyl β -aminoethylpiperazines have been prepared.
W E, LANGE, R N, LAZARUS, M E, AMUNDSON
openaire   +2 more sources

Derivatives of Piperazine. XXI. Synthesis of Piperazine and C-Substituted Piperazines

Journal of the American Chemical Society, 1947
L J, KITCHEN, C B, POLLARD
openaire   +2 more sources

Piperazine toxicity

Veterinary Record, 1987
openaire   +4 more sources

Piperazine

2021
openaire   +2 more sources

Piperazine

Reactions Weekly, 2014
A.M. Molina López, M.R. Moyano Salvago
openaire   +2 more sources